"10.1371_journal.pone.0026726","plos one","2011-11-07T00:00:00Z","Lingjun Zuo; Clarence K Zhang; Fei Wang; Chiang-Shan R Li; Hongyu Zhao; Lingeng Lu; Xiang-Yang Zhang; Lin Lu; Heping Zhang; Fengyu Zhang; John H Krystal; Xingguang Luo","Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, United States of America; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, United States of America; Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut, United States of America; Department of Psychiatry, The First Affiliated Hospital, China Medical University, Shenyang, China; Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas, United States of America; National Institute on Drug Dependence, Peking University, Beijing, China; Gene, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, United States of America","Conceived and designed the experiments: LZ FZ XL. Performed the experiments: XL LZ. Analyzed the data: LZ FZ XL CKZ HZ HPZ. Contributed reagents/materials/analysis tools: LZ FZ XL JHK. Wrote the paper: LZ FW CL FZ XL JHK. Result interpretation: JHK FZ XL LZ FW CL HZ HPZ XYZ LGL LL. Manuscript preparation and revision: LZ FW CL JHK FZ XL.","The authors have read the journals policy and have the following conflicts: JHK has been a paid consultant for Aisling Capital, LLC, AstraZeneca Pharmaceuticals, Brintnall & Nicolini, Inc., Easton Associates, Gilead Sciences, Inc., GlaxoSmithKline, Janssen Pharmaceuticals, Lundbeck Research USA, Medivation, Inc., Merz Pharmaceuticals, MK Medical Communications, F. Hoffmann-La Roche Ltd., SK Holdings Co., Ltd., Sunovion Pharmaceuticals, Inc., Takeda Industries and Teva Pharmaceutical Industries, Ltd. JHK serves as a member of Scientific Advisory Boards for Abbott Laboratories, Bristol-Myers Squibb, Eisai, Inc., Eli Lilly and Co., Forest Laboratories, Inc., Lohocla Research Corporation, Mnemosyne Pharmaceuticals, Inc., Naurex, Inc., Pfizer Pharmaceuticals and Shire Pharmaceuticals. JHK is the Editor for Biological Psychiatry, a member of Board of Directors of Coalition for Translational Research in Alcohol and Substance Use Disorders, and the President Elect for American College of Neuropsychopharmacology. JHK also gets support from Tetragenex Pharmaceuticals. Other authors have no conflicts of interest.","2011","11","Lingjun Zuo","LZ",12,TRUE,3,2,6,6,TRUE,TRUE,FALSE,0,NA,FALSE
